pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

COMPANY OVERVIEW

Cadent Therapeutics is rapidly advancing a pipeline of novel allosteric modulators of ion channels – taking a well-established pharmaceutical approach and stepping out into new territory.

LOCATION

  • Cambridge, MA, USA

    • THERAPEUTIC AREAS

  • Neurological Disorders

    • WEBSITE

    https://www.cadenttx.com

    CAREER WEBSITE

    https://www.cadenttx.com/careers/

    SOCIAL MEDIA

    INVESTORS

    access-industries atlas-venture cbi cowen-healthcare-investments novartis qiming-venture-partners slater-technology-fund

    PRESS RELEASES


    Dec 17, 2020

    Cadent Therapeutics Enters Agreement to be Acquired by Novartis


    Dec 17, 2020

    Saniona was informed today that Novartis plans to acquire Cadent Therapeutics, in which Saniona holds an ownership stake of approximately 3%


    Dec 17, 2020

    Cadent Therapeutics Enters Agreement to be Acquired by Novartis


    Aug 4, 2020

    Cadent Therapeutics to Present at the William Blair Biotech Focus Conference


    Jun 29, 2020

    Cadent Therapeutics to Participate in Upcoming Investor Conferences


    For More Press Releases
    Google Analytics Alternative